» Articles » PMID: 36249738

Aloe Vera for Prevention of Radiation-induced Dermatitis: A Systematic Review and Cumulative Analysis of Randomized Controlled Trials

Overview
Journal Front Pharmacol
Date 2022 Oct 17
PMID 36249738
Authors
Affiliations
Soon will be listed here.
Abstract

Aloe vera were frequently reported to reduce the risk of radiation-induced dermatitis (RID), but the quantitative results from all the relevant studies were not presently available. This study sought to conduct a cumulative analysis to better clarify the preventive effects of aloe vera in RID. MEDLINE (PubMed), Cochrane, EMBASE, PsychINFO, Web of Science, China National Knowledge Infrastructure (CNKI), and Wan Fang Database were utilized for identifying the eligible randomized controlled trials (RCTs) without language restrictions, up to March 2022. The pooled incidence of RID was conducted by the Relative risk (RR) with its 95% confidence interval (CI) through the STATA software under a random-effects model. This systematic review and cumulative analysis were registered on PROSPERO (ID: CRD42022335188). Fourteen RCTs met our predefined inclusion criteria, enrolling 1,572 participants (mean age: 46.5-56 years). The cumulative results revealed that patients pretreated with aloe vera were associated with a significantly lower risk of RID compared to those without aloe vera usage (RR = 0.76, 95% CI: 0.67-0.88, < 0.001; heterogeneity: = 79.8%, < 0.001). In the subgroup analysis, the pooled incidence of Grade 2-4, Grade 2, and Grade 3 RID was also dramatically lower in the group of aloe vera as compared to the placebo group [RR = 0.44 (0.27, 0.74), 0.58 (0.36, 0.94), and 0.27 (0.12, 0.59) in Grade 2-4, Grade 2, and Grade 3, respectively]. However, in regard to Grade 4 RID, the combined RR indicated that the incidence of RID was comparable between aloe vera and the control group (RR = 0.13, 95% CI: 0.02-1.01, = 0.051; heterogeneity: = 0.0%, = 0.741). The sensitivity analyses showed that there was no substantial change in the new pooled RR after eliminating anyone of the included study. The current cumulative analysis revealed that patients pretreated with aloe vera were less likely to suffer from RID than the controls without using aloe vera. Based on this finding, the prophylactic application of aloe vera might significantly reduce the incidence of RID, especially in Grade 2 and Grade 3 RID. Further large-sample multicenter RCTs are still warranted to confirm these findings and for better clinical application.

Citing Articles

Photobiomodulation therapy for mitigating severity of radiodermatitis in cancer patients undergoing radiotherapy: a scoping review.

Rao D, Dsouza C, Prabhu S, Kumar P, Prabhu V Support Care Cancer. 2024; 32(11):750.

PMID: 39467916 PMC: 11519231. DOI: 10.1007/s00520-024-08944-y.


The effect of various interventions on the prevention of radiation dermatitis: a network meta-analysis.

Cao H, Li W, Cai H Am J Transl Res. 2024; 16(5):1859-1879.

PMID: 38883361 PMC: 11170609. DOI: 10.62347/XLGT5405.

References
1.
Williams M, Burk M, Loprinzi C, Hill M, Schomberg P, Nearhood K . Phase III double-blind evaluation of an aloe vera gel as a prophylactic agent for radiation-induced skin toxicity. Int J Radiat Oncol Biol Phys. 1996; 36(2):345-9. DOI: 10.1016/s0360-3016(96)00320-3. View

2.
Hoopfer D, Holloway C, Gabos Z, Alidrisi M, Chafe S, Krause B . Three-Arm Randomized Phase III Trial: Quality Aloe and Placebo Cream Versus Powder as Skin Treatment During Breast Cancer Radiation Therapy. Clin Breast Cancer. 2015; 15(3):181-90.e1-4. DOI: 10.1016/j.clbc.2014.12.006. View

3.
Kong M, Hwang D, Lee J, Yoon S . The Efficacy and Safety of Jaungo, a Traditional Medicinal Ointment, in Preventing Radiation Dermatitis in Patients with Breast Cancer: A Prospective, Single-Blinded, Randomized Pilot Study. Evid Based Complement Alternat Med. 2016; 2016:9481413. PMC: 4811089. DOI: 10.1155/2016/9481413. View

4.
Goyal P, Gehlot P . Radioprotective effects of Aloe vera leaf extract on Swiss albino mice against whole-body gamma irradiation. J Environ Pathol Toxicol Oncol. 2009; 28(1):53-61. DOI: 10.1615/jenvironpatholtoxicoloncol.v28.i1.60. View

5.
Mortezaee K, Goradel N, Amini P, Shabeeb D, Musa A, Najafi M . NADPH Oxidase as a Target for Modulation of Radiation Response; Implications to Carcinogenesis and Radiotherapy. Curr Mol Pharmacol. 2018; 12(1):50-60. DOI: 10.2174/1874467211666181010154709. View